Remdesivir for 5 to 10 days in Patients with Severe COVID-19

Photo by Anna Shvets from Pexels

Originally published in New England Journal of Medicine, this article shares the results of treating 397 patients with severe COVID-19 infection using Remdesivir in 5 and 10 day groups.

COVID-19 News & Updates

Get the latest COVID-19 news, important information and updates from health care providers and experts.

Initial results, safety data from clinical trial shared during international medical conference
A recent Hear Me Now podcast examines research about long COVID and what the evidence shows.
Providence was recognized by Rep. Cathy McMorris Rogers (R-WA) for our commitment to scaling telehealth services throughout the pandemic and providing services to millions of patients.
Sherene Schlegel, Executive Director of Telehealth Clinical Operations spoke at a mHealth Intelligence panel on digital health literacy, in particular, among underserved populations.